New AI Partnership Streamlines Drug Discovery via Conversational Interfaces
SandboxAQ and Anthropic's partnership enables scientists to leverage advanced drug discovery tools through natural language, potentially reducing costs and timelines in research.
More from this archive
Anthropic Eases Restrictions on Claude Mythos Vulnerability Sharing
Anthropic has relaxed its confidentiality agreements for Claude Mythos, allowing broader sharing of security vulnerabilities found during testing.…
NVIDIA Launches Vera CPU with Unprecedented Specs for AI Development
NVIDIA's new Vera CPU, featuring 88 custom cores and record memory bandwidth, is now in production. The first…
Anthropic Eases Confidentiality for Mythos Cybersecurity Collaborators
Anthropic has lifted confidentiality constraints for partners in the Project Glasswing initiative, enabling them to share insights from…
SandboxAQ Enhances Anthropic’s Claude Chatbot for Drug Discovery
SandboxAQ has partnered with Anthropic to integrate drug discovery models into the Claude chatbot, significantly improving pharmaceutical research…
The archive
sorted by latest
Demis Hassabis Backs Anthropic as AI Sector Competitiveness Intensifies
GPUBeat Desk · 2 min
UK Investors Eye OpenAI and Anthropic Amid Anticipated IPOs
GPUBeat Desk · 2 min
Chamath Palihapitiya Critiques PwC and Accenture’s AI Integration Strategies
GPUBeat Desk · 2 min
UK Investors Eyeing OpenAI and SpaceX Prepare for Limited Access
GPUBeat Desk · 2 min
Anthropic Bolsters Claude’s Connectivity with Stainless Acquisition
GPUBeat Desk · 2 min